Literature DB >> 7114075

Ankylosing spondylitis: an important cause of severe disturbances of the cardiac conduction system. Prevalence among 223 pacemaker-treated men.

L Bergfeldt, O Edhag, L Vedin, H Vallin.   

Abstract

The cause of severe disturbances of the cardiac conduction system is seldom possible to establish clinically at pacemaker implantation, apart from cases of acute myocardial infarction or digitalis intoxication and in relatively rare cases of inflammatory disorders such as sarcoidosis and systemic sclerosis. Since cardiac manifestations, mainly conduction disturbances, occur in patients with ankylosing spondylitis, the prevalence of this disease was determined using radiologic screening for sacroiliitis in a population of 223 men who had permanently implanted pacemakers. Sacroiliitis was found in 19 men (8.5 percent), 15 of whom fulfilled the diagnostic criteria for ankylosing spondylitis. In six patients, sacroiliitis was asymptomatic and two of the patients were completely free of symptoms other than those originating from their heart manifestations. In seven of the 15 patients with ankylosing spondylitis and in the four patients with sacroiliitis without clinical criteria of ankylosing spondylitis, the diagnosis was previously unknown. Uveitis and aortic regurgitation occurred in five patients each, while peripheral arthritis was twice as common. The prevalence of sacroiliitis and ankylosing spondylitis of 8.5 and 6.7 percent, respectively, differ significantly (p less than 0.01) from the frequencies found in general Caucasian populations of 1 to 2 and 0.1 to 0.5 percent, respectively. HLA B27 was present in more than 80 percent of the patients with sacroiliitis and/or ankylosing spondylitis, compared with 8 to 10 percent in the general population. This strong association is in accordance with previous studies of patients with symptomatic sacroiliitis and/or ankylosing spondylitis. Thus sacroiliitis, diagnosed by x-ray, can be considered a marker for this relatively common rheumatic cause of severe disturbances of the cardiac conduction system.

Entities:  

Mesh:

Year:  1982        PMID: 7114075     DOI: 10.1016/0002-9343(82)90177-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

Review 1.  The heart in ankylosing spondylitis.

Authors:  T W O'Neill; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

Review 2.  Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions.

Authors:  Jürgen Braun; Klaus Krüger; Bernhard Manger; Matthias Schneider; Christof Specker; Hans Joachim Trappe
Journal:  Dtsch Arztebl Int       Date:  2017-03-24       Impact factor: 5.594

3.  Permanent pacemakers in nonagenarians.

Authors:  J E Elizabeth; G J Green
Journal:  Postgrad Med J       Date:  1991-07       Impact factor: 2.401

4.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 3 Clinical symptoms].

Authors:  U Kiltz; M Rudwaleit; J Sieper; D Krause; J-F Chenot; A Stallmach; S Jaresch; U Oberschelp; E Schneider; B Swoboda; H Böhm; A Heiligenhaus; U Pleyer; W-H Böhncke; M Stemmer; J Braun
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

5.  Heart conduction disturbance: an HLA-B27 associated disease.

Authors:  A J Peeters; S ten Wolde; M I Sedney; R R de Vries; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

Review 6.  Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery.

Authors:  Susan M Goodman; C Ronald Mackenzie
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

7.  Evaluation of cardiac autonomic functions in patients with ankylosing spondylitis via heart rate recovery and heart rate variability.

Authors:  Ergun Baris Kaya; Sercan Okutucu; Hakan Aksoy; Ugur Nadir Karakulak; Erol Tulumen; Oya Ozdemir; Fatma Inanici; Kudret Aytemir; Giray Kabakci; Lale Tokgozoglu; Hilmi Ozkutlu; Ali Oto
Journal:  Clin Res Cardiol       Date:  2010-06-29       Impact factor: 5.460

8.  Holter monitoring in ankylosing spondylitis patients during methylprednisolone pulse therapy.

Authors:  G Nasswetter; D J Piñeiro; O M Garcia Morteo; J A Maldonado Cocco; J C Barreira; M Vazquez Blanco
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

9.  Comorbidities in Argentine patients with axial spondyloarthritis: Is nephrolithiasis associated with this disease?

Authors:  Fernando Sommerfleck; Emilce Schneeberger; Gustavo Citera
Journal:  Eur J Rheumatol       Date:  2018-06-22

10.  Complete heart block in HLA B27 associated disease. Electrophysiological and clinical characteristics.

Authors:  L Bergfeldt; H Vallin; O Edhag
Journal:  Br Heart J       Date:  1984-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.